Fluvastatin in the first-line therapy of acute coronary syndrome: results of the multicenter, randomized, double-blind, placebo-controlled trial (the FACS-trial)Petr Ošťádal, Jana Čepová, Jiří Vejvoda et al.|Trials|2010Cited by 29